By Mary Gabb ([email protected]) In a previous issue of HOC , we outlined some of the commonly expressed pros and cons of direct-to-consumer advertising (DTCA), which is currently allowed only…
Details
By Julie Stauffer ([email protected]) Pharmaceutical companies depend on data – and lots of it – to develop drugs and measure their effectiveness. And many patients are eager to supply that…
Details
By Ruth Whittington ([email protected]) Many of us in health economics and outcomes research look at Canada as one of the leaders in the field; along with Australia , Canada was…
Details
By Julie Stauffer ([email protected]) Staying on top of new developments can be a daunting task in today’s hyper-connected world. If you’re feeling swamped in a sea of information, make the…
Details
By David Woods ([email protected]) While the Golden Age of the pharmaceutical industry is over, and its reputation similar to that of the tobacco and oil industries, there is hope at…
Details
By David Woods ([email protected]) Speaking at the March World Health Care Conference in Washington , DC , Joshua J Ofman, MD, vice president, global coverage and reimbursement for Amgen, said…
Details
By Ruth Whittington ([email protected]) According to Michael Wilks, Chairman of the Standing Committee of European Doctors (CPME; an organisation facing the challenges of its current 2 million doctors in 27…
Details
By David Woods ([email protected]) A meeting, according to my dictionary, is an assembly of persons for a specific purpose. Perhaps a more whimsical definition might be that of an anonymous…
Details
By Mary Gabb ([email protected]) Nowadays, healthcare is hotly debated, and not just for US presidential candidates. Virtually every western country is now grappling with the challenge of how to pay…
Details
By Heather Haley ([email protected]) Ever asked yourself: “Is there a better way to do this?” while sifting through 300 plus potential articles. PubMed offers several features that can dramatically improve…
Details
